Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. A bunch of people I know (including me) have gotten sick ...

At least $241 million in taxpayer funds was spent on transgender surgeries and animal experiments, prompting a congressional lawmaker to question the rationale behind the expenditures. Rep.

Henson) across the face during a heated confrontation on season 2 of Eli Stone. When asked about the scene, Devine shared, “Yes, they play that on the internet” before detailing the experience ...

This regularly scheduled sponsored column is written by Eli Tucker, Arlington-based Realtor and Arlington resident. If you would like to work with Eli and his team in Northern Virginia and the ...

Former Giants quarterback Eli Manning has previously expressed interest in NFL ownership, specifically with his former team. “It’s definitely something of interest,” Manning said in an ...

For years, Eli Lilly has been generating solid growth numbers -- but lately, they've been accelerating rapidly. The company is coming off a solid quarter where its revenue rose by 45% for the last ...

What is an Employment Linked Incentive (ELI) Scheme? The ELI Scheme is a government programme designed to increase the number of jobs created in the formal sector by offering financial incentives to ...

Rep. Eli Crane, R-Ariz., said this week he was drafting articles of impeachment against U.S. District Judge Paul Engelmayer of the U.S Southern District of New York, who on Saturday blocked the ...

Eli Tomac will sit out an indeterminate number of Monster Energy Supercross races as he heals from what turned out to be a broken fibula, suffered in a qualification incident in Round 5 at Raymond ...

MASH is a form of non-alcoholic liver disease. Credit: SEBASTIAN KAULITZKI / SCIENCE PHOTO LIBRARY via Getty Images. Eli Lilly is paying up to $630m for a Phase I metabolic-associated steatohepatitis ...